tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RNA Stock Latest News

Avidity Biosciences Signs Manufacturing Agreement with Lonza
Company AnnouncementsAvidity Biosciences Signs Manufacturing Agreement with Lonza
2m ago
8K
RNA
Avidity Biosciences reports Q2 EPS ($1.21), consensus (96c)
PremiumThe Fly
Avidity Biosciences reports Q2 EPS ($1.21), consensus (96c)
1h ago
RNA
Avidity Biosciences: Promising Pipeline and Strategic Developments Drive Buy Rating Amid Potential Novartis Takeover Interest
PremiumRatings
Avidity Biosciences: Promising Pipeline and Strategic Developments Drive Buy Rating Amid Potential Novartis Takeover Interest
12h ago
RNA
Disney reports Q3 beat and NFL deal, Uber authorizes $20B buyback: Morning Buzz
PremiumThe Fly
Disney reports Q3 beat and NFL deal, Uber authorizes $20B buyback: Morning Buzz
1d ago
U
GO
Avidity up over 20% to $46.05 after FT report of buyout interest
PremiumThe Fly
Avidity up over 20% to $46.05 after FT report of buyout interest
1d ago
RNA
Novo Nordisk made takeover approach to Avidity Biosciences, FT reports
PremiumThe FlyNovo Nordisk made takeover approach to Avidity Biosciences, FT reports
1d ago
NVO
RNA
Avidity jumps 3% to $39.47 after FT report of takeover approach
Premium
The Fly
Avidity jumps 3% to $39.47 after FT report of takeover approach
1d ago
RNA
Avidity Biosciences trading resumes
Premium
The Fly
Avidity Biosciences trading resumes
1d ago
RNA
Novartis makes takeover approach for Avidity Biosciences, FT reports
PremiumThe Fly
Novartis makes takeover approach for Avidity Biosciences, FT reports
1d ago
NVS
RNA
Avidity Biosciences trading halted, volatility trading pause
PremiumThe Fly
Avidity Biosciences trading halted, volatility trading pause
1d ago
RNA
Avidity Biosciences’ Phase 3 Study Update: Del-desiran for Myotonic Dystrophy
PremiumCompany Announcements
Avidity Biosciences’ Phase 3 Study Update: Del-desiran for Myotonic Dystrophy
8d ago
RNA
Avidity Biosciences completes enrollment in Phase 3 HARBOR clinical trial
PremiumThe Fly
Avidity Biosciences completes enrollment in Phase 3 HARBOR clinical trial
10d ago
RNA
Avidity Biosciences Gains FDA Breakthrough Therapy Designation
PremiumCompany AnnouncementsAvidity Biosciences Gains FDA Breakthrough Therapy Designation
15d ago
8K
RNA
Avidity Biosciences receives FDA BTD for delpacibart zotadirsen
Premium
The Fly
Avidity Biosciences receives FDA BTD for delpacibart zotadirsen
15d ago
RNA
Avidity Biosciences receivfes FDA BTD for delpacibart zotadirsen
Premium
The Fly
Avidity Biosciences receivfes FDA BTD for delpacibart zotadirsen
15d ago
RNA
Avidity, Phathom mentioned as potential takeout targets at Needham
PremiumThe Fly
Avidity, Phathom mentioned as potential takeout targets at Needham
21d ago
BMY
NVO
Avidity Biosciences Positioned for Leadership in Muscular Dystrophy with Strategic Regulatory Advancements
PremiumRatings
Avidity Biosciences Positioned for Leadership in Muscular Dystrophy with Strategic Regulatory Advancements
24d ago
RNA
Raymond James Predicts Up to ~760% Surge for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Raymond James Predicts Up to ~760% Surge for These 2 ‘Strong Buy’ Stocks
26d ago
RNA
ACHV
Avidity Biosciences price target raised to $70 from $60 at Evercore ISI
PremiumThe Fly
Avidity Biosciences price target raised to $70 from $60 at Evercore ISI
27d ago
RNA
Avidity Biosciences: Promising Advancements and Strategic Positioning Drive Buy Rating
PremiumRatingsAvidity Biosciences: Promising Advancements and Strategic Positioning Drive Buy Rating
28d ago
RNA
Avidity Biosciences resumed with a Buy at Goldman Sachs
Premium
The Fly
Avidity Biosciences resumed with a Buy at Goldman Sachs
29d ago
RNA
Avidity Biosciences’ Promising Phase 3 Study on FSHD Treatment: Market Implications
Premium
Company Announcements
Avidity Biosciences’ Promising Phase 3 Study on FSHD Treatment: Market Implications
1M ago
RNA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >